Quarterly report · Q1
4626.TEDINET S100RHN8
Period2023-04-01 → 2023-06-30
Filed2023-08-01
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.9bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥97.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥25.8bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥3.5bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥5.3bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥3.2bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥15.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.2bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.6bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.6bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.6bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥3.6bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥191.4bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥187.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥191.1bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥96.9bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥94.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥94.5bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥92.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥89.3bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥43.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥47.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥45.94 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥203.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.47 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.4% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥901m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥822m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥79m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | ¥18m |
| jpcrp040300-q1r_E00913-000Electronicsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥15.7bn |
| jpcrp040300-q1r_E00913-000Electronicsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥15.7bn |
| jpcrp040300-q1r_E00913-000Electronicsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.3bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥7.3bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥751m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥23.0bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥23.0bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥23.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥23.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥79m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥3.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥859m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥786m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥72m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥7m |
| jpcrp040300-q1r_E00913-000Electronicsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E00913-000Electronicsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E00913-000Electronicsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥5.2bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥482m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥25.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥25.0bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥25.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥25.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥72m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥5.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 342
| Item | Context | Value | Unit |
|---|---|---|---|
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -2000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -0 | JPY |
| Other comprehensive income | Prior1YTDDuration | 2334000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 2140000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 5954000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 4701000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 5954000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 4701000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -0 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 0 | JPY |
| Trade notes receivable transferred by endorsement | Prior1YearInstant | 610000000 | JPY |
| Trade notes receivable transferred by endorsement | CurrentQuarterInstant | 638000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | 19293000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 5678000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 24971000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 786000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 25757000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 72000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 72000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | 19293000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 5678000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 24971000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 859000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 25830000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | 5197000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 482000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 5679000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -7000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 5672000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | 15703000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 7335000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 23039000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 822000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 23861000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 79000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 79000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | 15703000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 7335000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 23039000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 901000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 23941000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00913-000ElectronicsReportableSegmentsMember | 2642000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 751000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 3393000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |